CG Oncology (CGON) Revenue (2023 - 2026)
CG Oncology's (CGON) quarterly Revenue came in at $1.1 million in Q1 2026, up 1982.69% YoY from $52000.0 in Q1 2025, and down 53.36% on a QoQ basis from $2.3 million in Q4 2025.
CG Oncology (CGON) Revenue (2023 - 2026) Analysis & Trends
CG Oncology (CGON) has 4 years of Revenue data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Revenue rose 1982.69% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (up 666.01% YoY) and the FY2025 annual result came in at $4.0 million, up 254.7% from the prior year.
- Revenue fell to $1.1 million in Q1 2026, from $2.3 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $2.3 million in Q4 2025 to a low of $1000.0 in Q4 2023.
- A 4-year average of $587818.2 and a median of $194000.0 in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2024 — Revenue jumped 45500.0% — and 2025, when it slumped 90.17%.
- Tracing CGON's Revenue over 4 years: stood at $1000.0 in 2023, then jumped by 45500.0% to $456000.0 in 2024, then jumped by 409.21% to $2.3 million in 2025, then sank by 53.36% to $1.1 million in 2026.
- The last three Revenue figures came in at $1.1 million (Q1 2026), $2.3 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 2.32 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 456,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Mar 31, 2024 | 529,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 194,000.00 |